Your browser doesn't support javascript.
loading
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
Kaye, Erica C; Smith, Jesse; Zhou, Yiwang; Bagatell, Rochelle; Baker, Justin N; Cohn, Susan L; Diller, Lisa R; Glade Bender, Julia L; Granger, M Meaghan; Marachelian, Araz; Park, Julie R; Rosenberg, Abby R; Shusterman, Suzanne; Twist, Clare J; Mack, Jennifer W.
Afiliação
  • Kaye EC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Smith J; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Zhou Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Bagatell R; Division of Oncology, Department of Pediatrics, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Baker JN; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Cohn SL; Department of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, Illinois, USA.
  • Diller LR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Glade Bender JL; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Granger MM; Department of Pediatric Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Marachelian A; Hematology and Oncology Center, Cook Children's Hospital, Fort Worth, Texas, USA.
  • Park JR; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Rosenberg AR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Shusterman S; Center for Clinical and Translational Research, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington, USA.
  • Twist CJ; Department of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington, USA.
  • Mack JW; Center for Clinical and Translational Research, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington, USA.
Cancer ; 130(7): 1101-1111, 2024 04 01.
Article em En | MEDLINE | ID: mdl-38100619
ABSTRACT

BACKGROUND:

Many parents of children with advanced cancer report curative goals and continue intensive therapies that can compound symptoms and suffering. Factors that influence parents to choose palliation as the primary treatment goal are not well understood. The objective of this study was to examine experiences impacting parents' report of palliative goals adjusted for time. The authors hypothesized that awareness of poor prognosis, recall of oncologists' prognostic disclosure, intensive treatments, and burdensome symptoms and suffering would influence palliative goal-setting.

METHODS:

The authors collected prospective, longitudinal surveys from parents of children with relapsed/refractory neuroblastoma at nine pediatric cancer centers across the United States, beginning at relapse and continuing every 3 months for 18 months or until death. Hypothesized covariates were examined for possible associations with parental report of palliative goals. Generalized linear mixed models were used to evaluate factors associated with parents' report of palliative goals at different time points.

RESULTS:

A total of 96 parents completed surveys. Parents were more likely to report a primary goal of palliation when they recalled communication about prognosis by their child's oncologist (odds ratio [OR], 52.48; p = .010). Treatment intensity and previous ineffective therapeutic regimens were not associated with parents' report of palliative goals adjusted for time. A parent who reported new suffering for their child was less likely to report palliative goals (OR, 0.13; p = .008).

CONCLUSIONS:

Parents of children with poor prognosis cancer may not report palliative goals spontaneously in the setting of treatment-related suffering. Prognostic communication, however, does influence palliative goal-setting. Evidence-based interventions are needed to encourage timely, person-centered prognostic disclosure in the setting of advanced pediatric cancer. PLAIN LANGUAGE

SUMMARY:

Many parents of children with poor-prognosis cancer continue to pursue curative treatments that may worsen symptoms and suffering. Little is known about which factors influence parents to choose palliative care as their child's main treatment goal. To explore this question, we asked parents of children with advanced neuroblastoma across the United States to complete multiple surveys over time. We found that the intensity of treatment, number of treatments, and suffering from treatment did not influence parents to choose palliative goals. However, when parents remembered their child's oncologist talking about prognosis, they were more likely to choose palliative goals of care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Neuroblastoma Limite: Child / Humans Idioma: En Revista: Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Neuroblastoma Limite: Child / Humans Idioma: En Revista: Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos